Standalone figures · ₹ crore
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 669 | 669 | 4,860 | 4,560 | 3,987 | 3,941 | 4,138 | |
| COGS | 388 | 388 | 2,822 | 2,537 | 2,150 | 2,088 | 2,298 |
| Gross profit | 281 | 281 | 2,039 | 2,023 | 1,837 | 1,853 | 1,840 |
| -419 | 184 | 1,226 | 1,528 | 1,434 | 1,379 | 1,368 | |
| 700 | 97 | 813 | 495 | 403 | 475 | 472 | |
| OPM % | 104.6% | 14.5% | 16.7% | 10.9% | 10.1% | 12.1% | 11.4% |
| Depreciation | 21 | 21 | 120 | 120 | 133 | 147 | 161 |
| Interest | 9 | 9 | 46 | 38 | 66 | 65 | 57 |
| 15 | -10 | 29 | 31 | 36 | 81 | 87 | |
| Profit before tax | -0 | 56 | 675 | 368 | 239 | 343 | 342 |
| Tax | — | 17 | 223 | 114 | 77 | 80 | 74 |
| Tax % | — | 30.5% | 33.1% | 31.1% | 32% | 23.3% | 21.7% |
| -0 | 39 | 452 | 253 | 162 | 263 | 268 | |
| PAT margin % | -0% | 5.8% | 9.3% | 5.6% | 4.1% | 6.7% | 6.5% |
| EPS (₹) | -3.3 | 14.8 | 28.4 | 15.9 | 10.2 | 16.5 | 16.8 |
| EPS adjusted (₹) | — | 2.4 | 28.4 | 15.9 | 10.2 | 16.5 | 16.8 |
| — | 2.4% | 17.6% | 31.4% | 49% | 30.2% | 29.7% | |
| Annual report | — | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 1,560 | 1,967 | 2,143 | 2,231 | 2,425 | 2,624 |
| 736 | 425 | 601 | 829 | 825 | 747 | |
| 928 | 1,244 | 1,299 | 1,264 | 1,255 | 1,337 | |
| Total equity & liabilities | 3,240 | 3,652 | 4,058 | 4,340 | 4,521 | 4,723 |
| 1,650 | 1,655 | 1,775 | 2,229 | 2,335 | 2,367 | |
| CWIP | 63 | 162 | 477 | 180 | 197 | 139 |
| Investments | 135 | 139 | 172 | 297 | 310 | 327 |
| 1,392 | 1,696 | 1,635 | 1,634 | 1,679 | 1,892 | |
| Total assets | 3,240 | 3,652 | 4,058 | 4,340 | 4,521 | 4,723 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Speciality Chemicals | 2,139.92 | 477.89 | 2,323.16 | 426.59 | 1,896.57 | 25.2 |
| Chemical Intermediates | 1,560.53 | -21.73 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 104 | 587 | 446 | 394 | 441 | 462 | |
| -29 | -221 | -475 | -464 | -211 | -108 | |
| -70 | -410 | 33 | 64 | -208 | -230 | |
| Net cash flow | 5 | -44 | 3 | -6 | 22 | 124 |
| Free cash flow | 77 | 362 | -0 | 53 | 225 | 328 |
| CFO / Operating profit % | 107.6% | 72.2% | 90.1% | 97.7% | 93% | 97.8% |
| 1,248.96 |
| 550.25 |
| 698.71 |
| -3.11 |
| Nutrition & Health Solutions | 722.61 | 30.37 | 614.93 | 153 | 461.93 | 6.57 |
₹ crore by fiscal year